医药瓶市场 - 全球产业规模、份额、趋势、机会和预测，按瓶子、按应用、按最终用户、按地区和竞争进行细分，2020-2030F

2024 年全球医药瓶市场价值为 73 亿美元，预计在预测期内将实现令人印象深刻的成长，到 2030 年的复合年增长率为 3.90%。医药瓶是专门用于储存、保护和分配药品、疫苗和其他医疗相关物质等药品的容器。这些瓶子在从製造到患者管理的整个生命週期中对于维护药物的完整性、安全性和有效性发挥着至关重要的作用。为了防止篡改和未经授权的访问，药瓶通常采用防篡改密封、带或收缩套。这些特征可以显示包裹是否已开启或损坏。药瓶上贴有标籤，其中包含重要信息，包括药品名称、剂量说明、有效期限、批号和製造商详细资讯。品牌和标籤对于产品识别和法规遵循至关重要。

主要市场驱动因素

技术进步

主要市场挑战

假冒和产品篡改

主要市场趋势

永续包装

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：顾客之声

第五章：全球药瓶市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依瓶子分类（滴管瓶、液体瓶、包装瓶）
  • 依用途分类（滴管、电子液体、液体、口腔护理）
  • 依最终用户（化学品、配药药房、医疗中心、製药、药品包装）
  • 按地区
  • 按公司分类（2024）
• 市场地图

第六章：亚太地区药瓶市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 印度
  • 澳洲
  • 日本
  • 韩国

第七章：欧洲药瓶市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 德国
  • 西班牙
  • 义大利
  • 英国

第 8 章：北美药瓶市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 墨西哥
  • 加拿大

第九章：南美洲药瓶市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲药瓶市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 最新动态
• 产品发布
• 合併与收购

第 13 章：全球医药瓶市场：SWOT 分析

第 14 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 15 章： 大环境分析

第 16 章：竞争格局

• Berry Plastics Global Inc.
• Amcor Plc.
• Schott AG
• West Pharmaceuticals Services Inc.
• Gerresheimer AG
• Aptar Group Inc.
• Nipro Corporation
• Becton & Dickinson CO.
• Westrock Company
• O. Berk Company LLC

第 17 章：策略建议

第18章调查会社について・免责事项

Global Pharmaceutical Bottles Market was valued at USD 7.30 billion in 2024 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 3.90% through 2030. Pharmaceutical bottles are specialized containers designed for the storage, protection, and dispensing of pharmaceutical products such as medications, vaccines, and other healthcare-related substances. These bottles play a crucial role in maintaining the integrity, safety, and efficacy of pharmaceutical products throughout their lifecycle, from manufacturing to patient administration. To prevent tampering and unauthorized access, pharmaceutical bottles often incorporate tamper-evident seals, bands, or shrink sleeves. These features indicate if the package has been opened or compromised. Pharmaceutical bottles are labeled with essential information, including the medication name, dosage instructions, expiration date, lot number, and manufacturer details. Branding and labeling are essential for product identification and regulatory compliance.

Key Market Drivers

Technological Advancements

Incorporating RFID (Radio-Frequency Identification) and NFC (Near Field Communication) technology into pharmaceutical bottle caps and labels allows for real-time tracking and monitoring of medication usage. This technology can provide dosage reminders, monitor temperature, and offer tamper-evident features. Advancements in child-resistant packaging technology have led to the development of sophisticated closures that are easy for adults to open but challenging for children. These closures often incorporate features like push-and-turn mechanisms or squeeze-and-turn caps. Tamper-evident seals and features, such as shrink bands and breakable caps, have become more advanced and reliable, ensuring the integrity of pharmaceutical products, and protecting against tampering. Serialization involves the unique identification of each pharmaceutical product and its packaging, typically using 2D barcodes or QR codes. This technology helps in tracking and tracing products throughout the supply chain, reducing the risk of counterfeiting and ensuring product authenticity. High-tech solutions like holograms, color-shifting inks, and specialty printing techniques have been employed to make pharmaceutical bottle labels and packaging resistant to counterfeiting.

Innovations in materials science have led to the development of sustainable packaging materials for pharmaceutical bottles. This includes bio-based plastics, recycled materials, and biodegradable options, reducing the environmental footprint of packaging. To protect the stability of pharmaceutical products, pharmaceutical bottles now come with advanced barrier properties. This helps to maintain the integrity of the contents by preventing moisture, oxygen, and UV light from affecting the medication.

Key Market Challenges

Counterfeiting and Product Tampering

Counterfeit pharmaceutical products can contain incorrect or substandard ingredients, posing serious health risks to patients. Tampered products may be contaminated or otherwise compromised, jeopardizing patient safety. Incidents of counterfeiting and tampering erode trust in pharmaceutical brands and the industry as a whole. Consumers may become wary of purchasing medications, leading to a decrease in patient adherence to prescribed treatments. Pharmaceutical companies are subject to strict regulatory requirements to ensure the safety and authenticity of their products. Failure to prevent counterfeiting and tampering can lead to regulatory non-compliance and legal consequences. The financial implications of counterfeiting and tampering are substantial. Pharmaceutical companies may incur costs related to product recalls, legal actions, and damage control. Additionally, they may experience revenue losses due to reduced sales and damaged brand equity. Incidents of counterfeiting and tampering can disrupt the pharmaceutical supply chain. This can lead to delays in delivering critical medications to patients and healthcare providers, potentially impacting public health during emergencies.

Key Market Trends

Sustainable Packaging

The use of eco-friendly materials for pharmaceutical bottles is on the rise. This includes the development and utilization of bio-based plastics, recycled plastics, and biodegradable materials. These materials reduce the environmental impact of packaging and promote circular economy principles. Sustainable packaging initiatives aim to reduce the use of single-use plastics and minimize plastic waste. Pharmaceutical companies are exploring ways to design bottles that use less plastic while maintaining product integrity and safety. Pharmaceutical bottle manufacturers are designing bottles that are easily recyclable. This encourages recycling efforts and reduces the environmental footprint of pharmaceutical packaging. Lightweight bottle designs are being adopted to reduce transportation costs and energy consumption during shipping. These designs maintain packaging integrity while using fewer resources. Some pharmaceutical companies are exploring reusable and refillable bottle systems, where patients can return empty bottles for refilling. This reduces the need for new packaging and minimizes waste. Sustainable sourcing of materials used in pharmaceutical bottles is a priority. This includes ensuring that raw materials are responsibly and ethically sourced. Sustainable packaging aims to reduce the carbon footprint associated with the production and transportation of pharmaceutical bottles. This is achieved through energy-efficient manufacturing processes and optimizing supply chain logistics. Sustainable packaging must also comply with pharmaceutical regulatory standards to ensure product safety and patient well-being. Growing consumer awareness and demand for sustainable products are pushing pharmaceutical companies to adopt eco-friendly packaging solutions, including sustainable bottles. Many pharmaceutical companies have committed to corporate social responsibility (CSR) initiatives, which include sustainable packaging practices as part of their broader sustainability goals.

Key Market Players

• Berry Plastics Group Inc.
• Amcor Limited
• Gerresheimer AG
• Aptar Pharma
• Westrock Company
• Beckton and Dickinson Co.
• West Pharmaceuticals Services Inc.
• Schott AG
• Nipro Corporation
• O.Berk Company LLC

Report Scope:

In this report, the Global Pharmaceutical Bottles Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pharmaceutical Bottles Market, By Bottle:

• Dropper Bottles
• Liquid Bottles
• Packer Bottles

Pharmaceutical Bottles Market, By Application:

• Droppers
• E-Liquid
• Liquid
• Oral Care

Pharmaceutical Bottles Market, By End-User:

• Chemical
• Compounding Pharmacies
• Healthcare Centers
• Pharmaceutical
• Pharmaceutical Packaging

Pharmaceutical Bottles Market, By region:

• North America
  • United States
  • Canada
  • Mexico
• Asia-Pacific
  • China
  • India
  • South Korea
  • Australia
  • Japan
• Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pharmaceutical Bottles Market.

Available Customizations:

Global Pharmaceutical Bottles Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pharmaceutical Bottles Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Bottle (Dropper Bottles, Liquid Bottles, Packer Bottles)
  • 5.2.2. By Application (Droppers, E-Liquid, Liquid, Oral Care)
  • 5.2.3. By End-User (Chemical, Compounding Pharmacies, Healthcare Centers, Pharmaceutical, Pharmaceutical Packaging)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. Asia Pacific Pharmaceutical Bottles Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Bottle
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. Asia Pacific: Country Analysis
  • 6.3.1. China Pharmaceutical Bottles Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Bottle
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. India Pharmaceutical Bottles Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Bottle
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Australia Pharmaceutical Bottles Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Bottle
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User
  • 6.3.4. Japan Pharmaceutical Bottles Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Bottle
      • 6.3.4.2.2. By Application
      • 6.3.4.2.3. By End User
  • 6.3.5. South Korea Pharmaceutical Bottles Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Bottle
      • 6.3.5.2.2. By Application
      • 6.3.5.2.3. By End User

7. Europe Pharmaceutical Bottles Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Bottle
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Pharmaceutical Bottles Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Bottle
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Pharmaceutical Bottles Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Bottle
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. Spain Pharmaceutical Bottles Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Bottle
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Pharmaceutical Bottles Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Bottle
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. United Kingdom Pharmaceutical Bottles Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Bottle
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. North America Pharmaceutical Bottles Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Bottle
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Pharmaceutical Bottles Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Bottle
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. Mexico Pharmaceutical Bottles Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Bottle
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Canada Pharmaceutical Bottles Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Bottle
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User

9. South America Pharmaceutical Bottles Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Bottle
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Pharmaceutical Bottles Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Bottle
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Pharmaceutical Bottles Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Bottle
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Pharmaceutical Bottles Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Bottle
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Middle East and Africa Pharmaceutical Bottles Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Bottle
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Pharmaceutical Bottles Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Bottle
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Pharmaceutical Bottles Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Bottle
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Pharmaceutical Bottles Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Bottle
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Pharmaceutical Bottles Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. PESTLE Analysis

16. Competitive Landscape

• 16.1. Berry Plastics Global Inc.
  • 16.1.1. Business Overview
  • 16.1.2. Company Snapshot
  • 16.1.3. Products & Services
  • 16.1.4. Financials (In case of listed companies)
  • 16.1.5. Recent Developments
  • 16.1.6. SWOT Analysis
• 16.2. Amcor Plc.
  • 16.2.1. Business Overview
  • 16.2.2. Company Snapshot
  • 16.2.3. Products & Services
  • 16.2.4. Financials (In case of listed companies)
  • 16.2.5. Recent Developments
  • 16.2.6. SWOT Analysis
• 16.3. Schott AG
  • 16.3.1. Business Overview
  • 16.3.2. Company Snapshot
  • 16.3.3. Products & Services
  • 16.3.4. Financials (In case of listed companies)
  • 16.3.5. Recent Developments
  • 16.3.6. SWOT Analysis
• 16.4. West Pharmaceuticals Services Inc.
  • 16.4.1. Business Overview
  • 16.4.2. Company Snapshot
  • 16.4.3. Products & Services
  • 16.4.4. Financials (In case of listed companies)
  • 16.4.5. Recent Developments
  • 16.4.6. SWOT Analysis
• 16.5. Gerresheimer AG
  • 16.5.1. Business Overview
  • 16.5.2. Company Snapshot
  • 16.5.3. Products & Services
  • 16.5.4. Financials (In case of listed companies)
  • 16.5.5. Recent Developments
  • 16.5.6. SWOT Analysis
• 16.6. Aptar Group Inc.
  • 16.6.1. Business Overview
  • 16.6.2. Company Snapshot
  • 16.6.3. Products & Services
  • 16.6.4. Financials (In case of listed companies)
  • 16.6.5. Recent Developments
  • 16.6.6. SWOT Analysis
• 16.7. Nipro Corporation
  • 16.7.1. Business Overview
  • 16.7.2. Company Snapshot
  • 16.7.3. Products & Services
  • 16.7.4. Financials (In case of listed companies)
  • 16.7.5. Recent Developments
  • 16.7.6. SWOT Analysis
• 16.8. Becton & Dickinson CO.
  • 16.8.1. Business Overview
  • 16.8.2. Company Snapshot
  • 16.8.3. Products & Services
  • 16.8.4. Financials (In case of listed companies)
  • 16.8.5. Recent Developments
  • 16.8.6. SWOT Analysis
• 16.9. Westrock Company
  • 16.9.1. Business Overview
  • 16.9.2. Company Snapshot
  • 16.9.3. Products & Services
  • 16.9.4. Financials (In case of listed companies)
  • 16.9.5. Recent Developments
  • 16.9.6. SWOT Analysis
• 16.10. O. Berk Company LLC
  • 16.10.1. Business Overview
  • 16.10.2. Company Snapshot
  • 16.10.3. Products & Services
  • 16.10.4. Financials (In case of listed companies)
  • 16.10.5. Recent Developments
  • 16.10.6. SWOT Analysis

17. Strategic Recommendations

18. About Us & Disclaimer